[6-K] IM Cannabis Corp. Current Report (Foreign Issuer)

Rhea-AI Filing Summary

IM Cannabis Corp. furnished a Current Report on Form 6-K that includes a press release dated September 5, 2025 announcing that the company "Regains Compliance with Nasdaq Stockholders' Equity Listing Requirement." The filing incorporates Exhibit 99.1 as the press release and is signed by Oren Shuster, Chief Executive Officer and Director. The document as provided is short and supplies the title and exhibit reference for the press release; it does not include the press release text or financial details.

Positive

• Regained Nasdaq compliance with the stockholders' equity listing requirement as announced on September 5, 2025.

Negative

• None.

Insights

Corporate Governance Analyst

Regaining a listing standard is a procedural positive that restores eligibility to trade on Nasdaq.

The filing states the company has regained compliance with Nasdaq's stockholders' equity listing requirement as of the referenced press release dated September 5, 2025. Restoring compliance typically removes delisting risk tied to that specific metric and allows the company to remain listed under Nasdaq rules.

Dependencies include the underlying equity calculation and any continuing conditions Nasdaq may impose; the filing does not provide those figures or any timeline for future reviews. Investors should note the filing only references the press release exhibit and contains no numerical equity data or follow-up milestones.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

Commission File Number: 001-40065

IM Cannabis Corp.
(Exact Name of Registrant as Specified in Charter)

3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒     Form 40-F ☐

CONTENTS

On September 5, 2025, IM Cannabis Corp. (the “Company”) issued a press release titled: “IM Cannabis Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement”. A copy of this press release is furnished herewith as Exhibit 99.1.

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-289571 and 333-288346) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

EXHIBIT INDEX

Exhibit No.
99.1	Press Release dated September 5, 2025, titled “IM Cannabis Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement”.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		IM CANNABIS CORP.
		(Registrant)
Date:	September 5, 2025	By:	/s/Oren Shuster
		Name:	Oren Shuster
		Title:	Chief Executive Officer and Director

FAQ

What did IM Cannabis (IMCC) file on Form 6-K?

The company furnished a Form 6-K that incorporates a press release titled "IM Cannabis Regains Compliance with Nasdaq Stockholders' Equity Listing Requirement" as Exhibit 99.1 dated September 5, 2025.

When was the press release announcing Nasdaq compliance dated for IMCC?

The press release is dated September 5, 2025.

Who signed the Form 6-K for IM Cannabis (IMCC)?

The Form 6-K is signed by Oren Shuster, Chief Executive Officer and Director.

Does the filing include the full press release text or financial figures?

No; the filing references Exhibit 99.1 (the press release title and date) but the supplied content does not include the press release text or any numeric equity figures.

Is there information about how Nasdaq compliance was achieved?

The provided filing text does not disclose the equity calculation, specific remedies, or actions taken to regain compliance.